[Brain-immune interactions and implications in psychiatric disorders].

OBJECTIVE This review will focus on the role of cytokines in the central nervous system and its implications to depressive disorder. We will then discuss the main findings of cytokine measurements in patients with major depressive disorder. METHOD We searched Pubmed for studies published from 1999-2007, using the keywords depression and cytokine; and depressive disorder and cytokine. We have focused on pro-inflammatory cytokine measurements in patients with depression syndrome using DSM-criteria. RESULTS Several lines of evidence suggest that cytokines have effects on depression, such as the induction of sickness behavior; clinical conditions related to cytokines that also overlap depressive symptoms; and immunotherapy that can lead to depressive symptoms attenuated by antidepressant treatment. Finally, patients with depression exhibit increased levels of pro-inflammatory cytokines, although conflicting results have been described. CONCLUSION Cytokines may play a role in the pathophysiology of some cases of depression, although a causal link has not been established yet. Further longitudinal studies are needed to determine patterns of cytokine in patients with major depressive disorder, taking into account confounding factors closely associated with the activation of pro-inflammatory cytokines. In addition, simultaneous measurements of multiple biomarkers could provide critical insights into mechanisms underlying major depressive disorder and a variety of common cytokine-related diseases.

[1]  P. Scully,et al.  Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.

[2]  S. A. Palácios,et al.  Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever , 2007 .

[3]  I. Christie,et al.  Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study. , 2006, Journal of immunological methods.

[4]  Tetsuya Takahashi,et al.  Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  C. Bai,et al.  Cytokines and serotonin transporter in patients with major depression , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  A. Dunn,et al.  Cytokines as mediators of depression: What can we learn from animal studies? , 2005, Neuroscience & Biobehavioral Reviews.

[7]  E. Göka,et al.  IL‐6 levels decrease with SSRI treatment in patients with major depression , 2005, Human psychopharmacology.

[8]  V. Arolt,et al.  Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. , 2005, Journal of affective disorders.

[9]  George P Chrousos,et al.  Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  Andrew H. Miller,et al.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. , 2005, Viral immunology.

[11]  E. Sternberg,et al.  Brain-immune interactions and disease susceptibility , 2005, Molecular Psychiatry.

[12]  Andrew H. Miller,et al.  Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.

[13]  W. Banks,et al.  Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. , 2004, European journal of pharmacology.

[14]  F. Ortuño,et al.  Lymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depression , 2004, Psychiatry Research.

[15]  L. Price,et al.  Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. , 2004, Journal of affective disorders.

[16]  F. Ortuño,et al.  Monocytic parameters in patients with dysthymia versus major depression. , 2004, Journal of affective disorders.

[17]  E. Sternberg,et al.  Neural immune pathways and their connection to inflammatory diseases , 2003, Arthritis research & therapy.

[18]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[19]  A. Serretti,et al.  Possible association between –G308A tumour necrosis factor-&agr; gene polymorphism and major depressive disorder in the Korean population , 2003, Psychiatric genetics.

[20]  Kenneth E Freedland,et al.  Depression, mortality, and medical morbidity in patients with coronary heart disease , 2003, Biological Psychiatry.

[21]  S. Maier,et al.  Inescapable shock induces resistance to the effects of dexamethasone , 2003, Psychoneuroendocrinology.

[22]  R. Krishnan,et al.  The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men , 2003, Psychosomatic medicine.

[23]  S. Tsai,et al.  Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response , 2003, Neuropsychopharmacology.

[24]  J. Chae,et al.  Tumor necrosis factor‐β gene polymorphism may not be associated with major depressive disorder in the Korean population , 2003, Psychiatry and clinical neurosciences.

[25]  D. Kasprowicz,et al.  Adaptive immunity in mice lacking the β2-adrenergic receptor , 2003, Brain, Behavior, and Immunity.

[26]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[27]  R. Carney,et al.  Clinical depression and inflammatory risk markers for coronary heart disease. , 2002, The American journal of cardiology.

[28]  G. Kenis,et al.  Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.

[29]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[30]  George P Chrousos,et al.  Depression: a major, unrecognized risk factor for osteoporosis? , 2001, Trends in Endocrinology & Metabolism.

[31]  E. Bosmans,et al.  Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis , 2001, European Neuropsychopharmacology.

[32]  A. Kersting,et al.  Inflammatory markers in major depression and melancholia. , 2001, Journal of affective disorders.

[33]  S. Yamawaki,et al.  Plasma Concentrations of Interleukin-1β, Interleukin-6, Soluble Interleukin-2 Receptor and Tumor Necrosis Factor α of Depressed Patients in Japan , 2001, Neuropsychobiology.

[34]  T. Pollmächer,et al.  Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-α and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine , 2000, Neuropsychopharmacology.

[35]  E. Bosmans,et al.  Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. , 2000, Polish journal of pharmacology.

[36]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[37]  H. Anisman,et al.  Interleukin-1β production in dysthymia before and after pharmacotherapy , 1999, Biological Psychiatry.

[38]  J. Levine,et al.  Cerebrospinal Cytokine Levels in Patients with Acute Depression , 1999, Neuropsychobiology.

[39]  T. Pollmächer,et al.  Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. , 1999, Journal of psychiatric research.

[40]  H. Anisman,et al.  Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features , 1999, Molecular Psychiatry.

[41]  S. Link,et al.  Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy , 1997, Biological Psychiatry.

[42]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[43]  V. Arolt,et al.  Cytokine Production and Serum Proteins in Depression , 1995, Scandinavian journal of immunology.

[44]  A. Rot,et al.  Normal human sweat contains interleukin‐8 , 1995, Journal of leukocyte biology.

[45]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[46]  G. Chrousos,et al.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Bauer,et al.  Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[48]  D. Kurcgant,et al.  Cytokine profiles in women with different subtypes of major depressive disorder. , 2007, Journal of psychiatric research.

[49]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[50]  S. A. Palácios,et al.  Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. , 2007, Molecular Immunology.

[51]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[52]  C. Nemeroff,et al.  Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. , 2006, The American journal of psychiatry.

[53]  Alan J. Thomas,et al.  Increase in interleukin-1beta in late-life depression. , 2005, The American journal of psychiatry.

[54]  Alan J. Thomas,et al.  Increase in interleukin-1 beta in late-life depression , 2005 .

[55]  Andrew H. Miller,et al.  Cytokines and psychopathology: lessons from interferon-alpha. , 2004, Biological psychiatry.

[56]  M. Maj,et al.  Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. , 2004, Journal of affective disorders.

[57]  D. Kasprowicz,et al.  Adaptive immunity in mice lacking the beta(2)-adrenergic receptor. , 2003, Brain, behavior, and immunity.

[58]  Z. Kronfol.  Cytokine Regulation in Major Depression , 2003 .

[59]  D. Remick.  Cytokines and Cytokine Receptors: Principles of Action , 2003 .

[60]  V. Arolt,et al.  Different immune patterns in melancholic and non-melancholic major depression , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[61]  S. Yamawaki,et al.  Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. , 2001, Neuropsychobiology.

[62]  H. Anisman,et al.  Interleukin-1 beta production in dysthymia before and after pharmacotherapy. , 1999, Biological psychiatry.

[63]  E. Wardle.  Cytokines: an overview. , 1993, The European journal of medicine.